rs113993970
Variant summary
Our verdict is Pathogenic. Variant got 16 ACMG points: 16P and 0B. PVS1PP5_Very_Strong
The NM_002775.5(HTRA1):c.904C>T(p.Arg302Ter) variant causes a stop gained change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000112 in 1,613,732 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★). Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_002775.5 stop_gained
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 16 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
HTRA1 | NM_002775.5 | c.904C>T | p.Arg302Ter | stop_gained | 4/9 | ENST00000368984.8 | NP_002766.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
HTRA1 | ENST00000368984.8 | c.904C>T | p.Arg302Ter | stop_gained | 4/9 | 1 | NM_002775.5 | ENSP00000357980 | P1 | |
HTRA1 | ENST00000648167.1 | c.586C>T | p.Arg196Ter | stop_gained | 4/9 | ENSP00000498033 | ||||
HTRA1 | ENST00000420892.1 | c.127C>T | p.Arg43Ter | stop_gained | 1/6 | 2 | ENSP00000412676 |
Frequencies
GnomAD3 genomes AF: 0.0000329 AC: 5AN: 152070Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.00000796 AC: 2AN: 251218Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 135828
GnomAD4 exome AF: 0.00000889 AC: 13AN: 1461662Hom.: 0 Cov.: 32 AF XY: 0.00000825 AC XY: 6AN XY: 727130
GnomAD4 genome AF: 0.0000329 AC: 5AN: 152070Hom.: 0 Cov.: 32 AF XY: 0.0000269 AC XY: 2AN XY: 74278
ClinVar
Submissions by phenotype
not provided Pathogenic:3
Pathogenic, criteria provided, single submitter | clinical testing | Clinical Genetics Laboratory, Skane University Hospital Lund | Jan 23, 2024 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Sep 19, 2022 | For these reasons, this variant has been classified as Pathogenic. Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may create or strengthen a splice site. ClinVar contains an entry for this variant (Variation ID: 7488). This premature translational stop signal has been observed in individual(s) with HTRA1-related conditions (PMID: 19387015, 32101834). This variant is present in population databases (rs113993970, gnomAD 0.003%). This sequence change creates a premature translational stop signal (p.Arg302*) in the HTRA1 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in HTRA1 are known to be pathogenic (PMID: 19387015, 29895533). - |
Pathogenic, criteria provided, single submitter | clinical testing | GeneDx | Jan 11, 2024 | Published functional studies demonstrate a damaging effect, as this variant shows significantly reduced protease activity, results in the oblation of complexes with alpha1-antitrypsin, and increases expression of an extra domain-A region of fibronectin, resulting in significant functional impairment (PMID: 19387015); Nonsense variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss of function is a known mechanism of disease; This variant is associated with the following publications: (PMID: 25525159, 26063658, 32581362, 26944136, 19387015, 27634960, 34433685, 32101834, 34270682) - |
CARASIL syndrome Pathogenic:1Other:1
not provided, no classification provided | literature only | GeneReviews | - | - - |
Pathogenic, no assertion criteria provided | literature only | OMIM | Apr 23, 2009 | - - |
Seizure;C0240735:Personality changes;C0338656:Cognitive impairment Pathogenic:1
Likely pathogenic, no assertion criteria provided | research | NIHR Bioresource Rare Diseases, University of Cambridge | - | - - |
Cerebral arteriopathy, autosomal dominant, with subcortical infarcts and leukoencephalopathy, type 2 Pathogenic:1
Likely pathogenic, criteria provided, single submitter | clinical testing | Johns Hopkins Genomics, Johns Hopkins University | May 04, 2020 | This HTRA1 variant (rs113993970) is rare (<0.1%) in a large population dataset (gnomAD: 3/282606 total alleles; 0.001%; no homozygotes) and has been reported previously in patients with cerebral small-vessel disease8. This nonsense variant results in a premature stop codon in exon 4 likely leading to nonsense-mediated decay and lack of protein production. We consider this variant to be likely pathogenic. - |
Small vessel cerebrovascular disease Pathogenic:1
Likely pathogenic, no assertion criteria provided | research | NIHR Bioresource Rare Diseases, University of Cambridge | - | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at